Skip to main content
. 2004 Nov;57(11):1172–1178. doi: 10.1136/jcp.2004.019026

Table 1.

 Clinicohistopathological and karyotypic data

Case Age/Sex Indication Location (Size (cm)) P/R/M RT-PCR Karyotype
1a 45/M MPNST Ankle P (biopsy) NP 42,XY,-3,add(4)(q35),add(11)(p14),-12,-14,add(19)(q13.4),-21,-21,-22,-22,+mar1,+mar2,+mar3[9]/42,XY,idem,add(1)(p36),del(7)(q31)[3]/46,XY[11]
1b 45/M MPNST Ankle (6.2×6.0×2.8) R (resection) NP 42,XY,del(1)(q35),del(2)(q23),add(4)(q35),+5,del(7)(q31),-9,-9,add(11)(q23),-12,-19,add(19)(q13.4),-21,-22,+mar1,+mar[cp14]/46,XY[7]
2 78/M Epithelioid MPNST Thigh/buttock (1.5×1.0×0.5) P (biopsy) Negative 43,XY,i(1)(q10),+8,-9,-11,del(12)(p11.1),-18,-22[6]/46,XY[14]
3* 37/M MPNST Lung (1.8×1.2×1.0) M (resection) NP 65,XXY,add(3)(p11.2),add(5)(q35)×2,del(7)(q11.1q34)×2,add(9)(p23),-10,add(13)(p11.1),add(14)(q32)×2,-16,-19,-19,add(20)(q13.3),add(22)(q11.2)×2,1∼3dmin[cp3]/92,XXYY[4]/46,XY[14]
4* 16/M MPNST Thigh (3.0×2.0×0.5) P (biopsy) Negative 46,XY,t(1;3)(p36.1;q11.2),del(7)(q32),+i(8)(q10),del(9)(p13),-10,del(11)(q14),der(12)t(1;12)(q23;p12),der(14)t(10;14)(q11.2;p11.2), der(15)t(15;21) (q26;q?)?dup(21),add(20)(q13.2),-21,add(22)(q11.2),+mar1, 1∼3dmin[cp17]/92, idem×2[cp3]/46,XY[8]
5 72/F MPNST Thigh (17×6.5×6.5) P (resection) Negative 72,XXX,+1,add(1)(p31)×2,del(2)(p13p23),del(4)(p14p16)×2,del(6)(q13q26)×2,+7,add(7)(q36)×2,+8,-9,-10,del(11)(q23),+12,-14,-15,-16,-17,-18, +add(19)(q13.3),+20,+21,+mar1,+mar2,+mar3,1∼5dmin[cp8]/46,XX[2]
6 28/M MPNST Neck (8.0×6.5×2.8) R (resection) NP 60∼70,XY,-X,-1,add(1)(p36.3),-3,-6,-8,-9,-10,add(11)(q22),del(11)(q21),-13,-14,-15,add(15)(q24),add(16)(q21),add(16)(q24),-17,-17,-17,+add(19)(q13.2),-20,+21,add(22)(q11.2),+mar1,+mar2,+mar3,+mar4,+mar5,+mar6×2,+mar7,+mar8,+1∼4mar[cp17]
7 28/F MTT Axilla (11.0×4.0×3.0) P (resection) Negative 64,XX,-X,+1,der(1)t(1;15)(p11;q11.1)×2,+2,-3,-4,+5,-6,+7,+8,-9,-10,-11,-12,-13,-14,-15,-15,-15,-16,+17,+18,+20,+21[5]/46,XX[15]
8* 21 months/F MPNST Shoulder (2.5×1.5×1.5) P (biopsy) Negative 58,XX,-X,-1,-3,-4,-5,-6,+7,+8,-9,-10,-11,-13,-14,+15,-16,-17,-18,-22,+mar[10]
9a† 25/F MTT Forearm (1.5×1.5×3.0) R (resection) NP 47,XX,t(1;2)(p13;p25),t(3;14)(p12;q31),ins(4;?5)(q28;?q22q32),-5,add(9)(p24),add(15)(q26),add(22)(q13),+mar1,+mar2[5]/47,XX,add(6)(p25),t(7;8)(p11;p11),t(12;21)(q21;q21),+22[4]/47,XX,t(2;10)(q31;p15),t[3;der(7)][p13;q36],der(7)t(7;?7)(p22;?q?),+mar[2]/46,XX[2]
9b 27/F MTT Forearm R (biopsy) NP 44,XX,-2,-3,del(3)(p13),-4,add(6)(q27),der(7)t(7;?7)(p22;?q?),-10,der(12)t(12;21)(q24;q21),add(13)(q34),add(15)(q26),-16,-17,-21,+mar1,+mar2,+mar3,+mar4,+mar5[cp7]
9c 27/F MTT Forearm (5.0×2.0×2.0) R (resection) neg. 45,XX,-2,-3,del(3)(p13),ins(4;?5)(q28;?q22q32),add(6)(q27),der(7)t(7;?7)(p22;?q?),add(13)(q34),add(15)(q26),-16,-17,-21,+mar1,+mar2,+mar3,+mar4[cp19]
10 50/F MPNST Shoulder (9.0×7.5×7.5) P (resection) NP 71∼82,XXX,del(1)(q21)×2,add(2)(q?),del(4)(p13),-5,-5,+del(7)(p11),-8,-8,-9,-9,-10,-10,del(12)(p11),+14,add(16)(q24),add(20)(q11),+mar1,+mar2,inc[cp3]/46,XX[9]
11* 26/M MPNST Pelvis (19.0×10.0×7.5) P (resection) Negative 71-75,XY,-X or -Y,-3,dic(3;9)(q11;p11)×2,-4,del(4)(q28q35),der(7)del(7)(q22)t(1;17;7)(?;?;p22)×2,der(7)t(7;7)(p22;?),+der(7)t(7;7)(p22;?),-8,add(8)(q24.3)×2,-9,-9,+11,del(11)(q23)×2,del(12)(q24), +der(14)t(7;14)(?;p11),-15,-16,-16,-16,-17,der(17)del(17)(p13)t(17;17)(q25;?)×2,+18,der(19)t(13;19;21)(q?;?p11q11;q?)×2,der(20)t(12;20)(?q13;p13)×2,der(21)t(17;21)(?;q22)×2,der(22)t(8;22)(?;p11),der(22)t(8;17;22)(?;?;p11), +mar1,+mar2,+mar3×2,+5∼9mar[cp20]/46,XY[2]
12*† 35/F MPNST Foot (4.5×3.0×3.0) P (biopsy) Negative 47∼65,XX,del(1)(p31),+del(3)(q13.3),+del(6)(q21)×2,+del(6)(q27)×2,del(7)(q21),add(12)(q24),+add(16)(q24),add(20)(q11.2),-21,+mar1,+mar2,+6mar[cp3]/46,XX[44]
13a*† 17/F MTT Knee P (biopsy) Negative 69,XX,-X,del(1)(p21),-3,+der(5)t(5;?9)(p13;?q13),der(5)t(5;?9)(p13;?q13),+7,+8,+8,-9,-9,-9,-10,-10,dup(11)(p11.2p15),+del(12)(q15),del(12)(q15),-13,-14,-16,-17,-18,+21,-22,+mar1×2,+mar2,+mar3,+3mar[cp20]/46,XX[12]
13b*† 17/F MTT Knee (5.5×5.5×20.0) P (resection) Negative 64,XX,?del(X)(q22),+?del(X)(q22),-1,-2,der(5)t(5;?9)(p13;?q13),+7,-9,-10,-11,-12,-16,-17,-18,+mar1,+mar1[12]/42,X,del(X)(q22),-1,-3,der(5)t(5;?9)(p13;?q13),-9,-11,-14,-17,-18,+mar1,+mar2,+mar3[7]/46,XX[1]
14* 60/M MPNST Lumbar region (25.0×23.0×10.0) P (resection) NP 44,XY,del(3)(p21),del(10)(q22),-13,-16,del(20)(q13.3),add(22)(q11.2)[3]/46,XY[21]
15* 32/F MPNST Upper arm (4.5×2.5×2.0) P (resection) Negative 46,XX,add(1)(q21),-6,-10,-14,-18,+mar1,+mar2,+mar3,+mar4,inc[cp12]/46,XX[9]
16† 27/F MTT Paraspinal (5.6×8.4×14.3) P (resection) NP 63,XX,-X,+dic(1;22)(p36;p10),+del(2)(q33),t(2;?12)(p25;?),-3,add(4)(q34),+5,dic(7;?11)(p22;?),-10,-11,der(11)t(5;11)(q11;q23),-12,-12,-14,add(14)(p11),-15,-16,add(16)(p13),-17,-18,-19,-20,del(20)(q13),?add(21)(q22),+mar1,+mar2,+mar3,+mar4,2∼8dmin[cp5]
17* 20/M MPNST Lower leg (28×20×15 cm) P (resection) NP 67,XXY,+add(1)(p35),+3,-13,add(19)(q13),-20,-20,-21[8]/46,XY[13]

*Patients with neurofibromatosis type I; †these karyotypes have been reported previously.5,6

MPNST, malignant peripheral nerve sheath tumour; MTT, malignant triton tumour; NP, not performed; P/R/M, primary, recurrent, or metastatic lesion; RT-PCR, reverse transcription polymerase chain reaction.